SCHEMBL4630468

SCHEMBL4630468

Cn1cncc1C#Cc1cccc(C(N)=O)c1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 5/20 0.49
KDR P35968 4/20 0.49
GRM5 P41594 3/20 0.49
TDP1 Q9NUW8 3/20 0.47
CYP3A4 P08684 1/20 0.41
HTR1A P08908 1/20 0.41
CYP2D6 P10635 1/20 0.41
DRD2 P14416 1/20 0.41
HTR7 P34969 1/20 0.41
HTR6 P50406 1/20 0.41
PSMD14 O00487 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
MAP3K14 Q99558 1/20 0.40
PARP1 P09874 4/20 0.40
NMT1 P30419 1/20 0.37
PIKFYVE Q9Y2I7 1/20 0.37
PARP15 Q460N3 1/20 0.37
PARP10 Q53GL7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4630469 0.79 TDP1 (0.49) FGFR3KDRGRM5TDP1PSMD14
SCHEMBL6208653 0.75 TDP1 (0.52) FGFR3KDRGRM5TDP1PSMD14
SCHEMBL29506350 0.75 F7 (0.59) GRM5CYP3A4CYP2D6
SCHEMBL12203286 0.74 TDP1 (0.47) FGFR3KDRGRM5TDP1PSMD14
SCHEMBL4417743 0.73 HPGD (0.59)
SCHEMBL16719361 0.72 GRM5 (0.55) GRM5TDP1CYP3A4PARP1
SCHEMBL18946169 0.72 GRM5 (0.55) GRM5TDP1CYP3A4MAP3K14PARP1
SCHEMBL12478968 0.71 GRM5 (0.55) GRM5TDP1CYP3A4MAP3K14PARP1
SCHEMBL29760240 0.70 GRM5 (0.56) GRM5PARP1PARP10
SCHEMBL4711689 0.69 GRM5 (0.66) GRM5CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919875-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS Astex Therapeutics Limited (GB) 2008-05-14 EP claimed
WO-2006136829-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 WO claimed
EP-1919875-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS Astex Therapeutics Limited (GB) 2008-05-14 EP disclosed
WO-2006136829-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 WO disclosed